Next Article in Journal
Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?
Previous Article in Journal
Wnt Signaling in Cancer Stem Cell Biology
Previous Article in Special Issue
Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lung Cancer
Article Menu

Export Article

Open AccessReview
Cancers 2016, 8(7), 61; doi:10.3390/cancers8070061

Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection

1
Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA
2
Division of Hematology/Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI 48109, USA
3
Section of Thoracic Surgery, Department of Surgery, University of Michigan, Taubman Center 2120, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Bingliang Fang
Received: 2 May 2016 / Revised: 8 June 2016 / Accepted: 17 June 2016 / Published: 28 June 2016
(This article belongs to the Special Issue Lung Cancer Biomarkers)
View Full-Text   |   Download PDF [205 KB, uploaded 28 June 2016]

Abstract

Improving early detection of lung cancer is critical to improving lung cancer survival. Studies have shown that computerized tomography (CT) screening can reduce mortality from lung cancer, but this involves risks of radiation exposure and can identify non-cancer lung nodules that lead to unnecessary interventions for some. There is a critical need to develop alternative, less invasive methods to identify patients who have early-stage lung cancer. The detection of circulating tumor cells (CTCs) are a promising area of research, but current technology is limited by a low yield of CTCs. Alternate studies are investigating circulating nucleic acids and proteins as possible tumor markers. It is critical to develop innovative methods for early lung cancer detection that may include CTCs or other markers that are low-risk and low-cost, yet specific and sensitive, to facilitate improved survival by diagnosing the disease when it is surgically curable. View Full-Text
Keywords: biomarkers; circulating tumor cells; microRNA; lung cancer; proteomics biomarkers; circulating tumor cells; microRNA; lung cancer; proteomics
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Murlidhar, V.; Ramnath, N.; Nagrath, S.; Reddy, R.M. Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection. Cancers 2016, 8, 61.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top